Partner Content Partner Content Featured speakers for 2nd annual Wearable Injectors and Conn... Featured speakers for 2nd annual Wearable Injectors
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
